Answer
Diarrhoea, nausea and vomiting occurred in more than 20% of patients receiving Cotellic with vemurafenib in Study GO28141, with higher frequencies than in the placebo-plus-vemurafenib arm.
Sources for this answer
- Cotellic 20 mg film-coated tabletsRoche Products Limited · emc · SmPC §4.8 Undesirable effects · Version 14Document updated
Sources checked